Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation [2]

Journal of Internal Medicine

Volumn 253, Issue 3, 2003, Pages 391-392

  Candelli, M ^a   Nista, E C ^a   Pignataro, G ^a   Zannoni, G ^a   De Pascalis, B ^a   Gasbarrini, G ^a   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MITOCHONDRION ANTIBODY; ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ANAMNESIS; BIOPSY; BLOOD ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIARRHEA; DISEASE EXACERBATION; FATTY LIVER; FECES CULTURE; HEMATOCHEZIA; HUMAN; INTESTINE MOTILITY; LABORATORY TEST; LETTER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; ULCERATIVE COLITIS; VIRUS DETECTION; ADULT; CASE REPORT; CHEMICALLY INDUCED DISORDER; MALE;

ADULT; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; FATTY LIVER; HUMANS; MALE; METHYLPREDNISOLONE;

EID: 0037337224     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01108.x     Document Type: Letter

References (5)

1. Seki K, Minami Y, Nishikawa M et al. Non alcoholic steatohepatitis induced by massive doses of synthetic estrogen. Gastroenterol Jpn 1983; 18: 197-203.
2. Itoh S, Igarashi M, Tsukada Y. Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy. Acta Hepato Gastroenterol 1977; 24: 415-8.
3. Nanki T, Koike R, Miyasaka N. Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis. Am J Gastroenterol 1999; 94: 3379.
4. Dourakis SP, Sevastianos VA, Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. Am J Gastroenterol 2002; 97: 1074-5.
5. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001; 121: 710-23.